Cabaletta Bio, Inc. (CABA)
NASDAQ: CABA · Real-Time Price · USD
2.550
-0.150 (-5.56%)
Nov 5, 2025, 10:58 AM EST - Market open
Cabaletta Bio Market Cap
Cabaletta Bio has a market cap or net worth of $233.24 million as of November 5, 2025. Its market cap has decreased by -2.66% in one year.
Market Cap
233.24M
Enterprise Value
77.17M
1-Year Change
-2.66%
Ranking
Category
Stock Price
$2.55
Market Cap Chart
Since October 25, 2019, Cabaletta Bio's market cap has decreased from $235.53M to $233.24M, a decrease of -0.97%. That is a compound annual growth rate of -0.16%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 4, 2025 | 246.96M | 122.58% |
| Dec 31, 2024 | 110.95M | -88.59% |
| Dec 29, 2023 | 972.68M | 260.85% |
| Dec 30, 2022 | 269.55M | 151.03% |
| Dec 31, 2021 | 107.38M | -64.23% |
| Dec 31, 2020 | 300.21M | -10.59% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Oct 25, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 785.81B |
| Johnson & Johnson | 453.18B |
| AbbVie | 384.23B |
| UnitedHealth Group | 304.14B |
| AstraZeneca | 253.98B |
| Novartis AG | 237.13B |
| Novo Nordisk | 216.87B |
| Abbott Laboratories | 213.88B |